FARMINGDALE, N.Y., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq:MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that the Company’s President and Chief Executive Officer, Stavros Vizirgianakis, will ring the Nasdaq Stock Market Closing Bell on Wednesday, January 10, 2018. The ceremony is being held to celebrate the Company’s 25 years of listing on the Nasdaq.
“Throughout Misonix’s 59 year history, we have actively managed our product portfolio to develop the world’s best ultrasonic surgical platform for precision tissue removal with the goal of radically improving patient outcomes for chronic global healthcare issues in some of the largest surgical markets,” said Stavros Vizirgianakis, President and Chief Executive Officer of Misonix. “Misonix is honored to ring the Nasdaq Closing Bell in celebration of our 25 years as a publicly listed company. We view the Nasdaq ceremony not just as a celebration of the significant progress we have made, but also as a tribute to our dedicated employees and directors, and loyal customers and shareholders who continue to support and drive our success.”
“We are excited about the opportunities that lie ahead as Misonix continues to make significant progress on several key strategic initiatives that we believe will significantly further our ability to be a standard of care in operating rooms and hospital outpatient departments both across the US and worldwide. With a performance-based culture, a focus on driving sales of consumable and recurring revenue products and the ongoing expansion into new markets, I am confident Misonix has a bright future ahead.”
The Nasdaq Closing Bell will ring at 4:00 p.m. ET and interested parties can view a live stream of the event online at https://new.livestream.com/nasdaq/live. Photos and videos of the Closing Bell ceremony and related celebration will also be available, courtesy of the Nasdaq, on both Facebook (http://www.facebook.com/NASDAQ) and Instagram (http://instagram.com/nasdaq).
Mr. Vizirgianakis will be joined at the Nasdaq MarketSite in Times Square by members of the Company’s senior leadership team, Misonix employees and several of the Company’s partners.
About Misonix, Inc.
Misonix, Inc. (Nasdaq:MSON) designs, develops, manufactures and markets the world's leading ultrasonic medical devices for the precise removal of hard and soft tissue, including bone removal, wound debridement and ultrasonic aspiration. Misonix is focused on leveraging its proprietary ultrasonic technology to become the standard of care in operating rooms and clinics around the world. Misonix's proprietary ultrasonic medical devices are used in a growing number of medical procedures, including spine surgery, neurosurgery, orthopedic surgery, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications. At Misonix, Better Matters to us. That is why throughout the Company’s 59-year history, Misonix has maintained its commitment to medical technology innovation and the development of ultrasonic surgical products that radically improve patient outcomes. Additional information is available on the Company's web site at www.misonix.com.
Contact:
Joe Dwyer Joseph Jaffoni, Norberto Aja, Jennifer Neuman
Chief Financial Officer JCIR
Misonix, Inc. 212-835-8500 or mson@jcir.com
631-694-9555